Cytopathic effect inhibition assay for determining the in-vitro susceptibility of herpes simplex virus to antiviral agents

J Antimicrob Chemother. 1999 Nov;44(5):705-8. doi: 10.1093/jac/44.5.705.

Abstract

We compare a rapid dilution method for the determination of antiviral susceptibility of herpes simplex virus (HSV) with the plaque reduction assay. A total of 84 HSV clinical isolates were studied by both methods to detect in-vitro resistance to acyclovir and foscarnet. The rapid method showed for the detection of HSV isolates resistant to acyclovir and foscarnet, a sensitivity of 96. 8% and 100% and specificity of 100% and 100%, respectively. This method provides an easy and accurate screening procedure for the susceptibility testing of HSV to antiviral agents.

MeSH terms

  • Acyclovir / pharmacology*
  • Antiviral Agents / pharmacology*
  • Foscarnet / pharmacology*
  • Herpes Simplex / virology
  • Herpesvirus 1, Human / drug effects*
  • Herpesvirus 1, Human / isolation & purification
  • Herpesvirus 2, Human / drug effects*
  • Herpesvirus 2, Human / isolation & purification
  • Humans
  • Microbial Sensitivity Tests / methods
  • Sensitivity and Specificity
  • Viral Plaque Assay / methods*

Substances

  • Antiviral Agents
  • Foscarnet
  • Acyclovir